Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&D and production services CDMO include R&D services, commercial human drug projects, commercial veterinary drug projects and other commercial projects; pharmaceutical business includes anti-infective, cardiovascular, psychotropic, hepatobiliary and anti-tumor categories. The company also provides technology platforms, such as flow chemistry, synthetic biology and biocatalysis, crystallization and particle engineering, peptide, high potency compound, conjugate library service, oligonucleotide synthesis, and preparation and purification; and controlled-release formulation development, taste masking technology, and particle flow simulation. In addition, it exports its products under the Tianliwei, Baishixin, Li'an, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 000739-SZ would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1997) — listing | $310,707 7.2× | $443,040 7.1× |
| Year 6 (2002) | $221,347 6.1× | $316,966 6.0× |
| Year 11 (2007) | $94,836 3.4× | $139,264 3.3× |
| Year 16 (2012) | $45,896 2.2× | $67,790 2.2× |
| Year 21 (2017) | $19,383 1.4× | $28,598 1.4× |
| Year 26 (2022) | $6,566 1.0× | $9,673 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 000739
For illustration only — not investment advice. Past performance is not indicative of future results.